A methotrexate-associated lymphoproliferative disorder expressing CD10 and BCL6 with the IGH/CCND1 translocation.

Authors :: Katsuya H
Kizuka-Sano H
Yokoo M
Kidoguchi K
Yamaguchi K
Nishioka A
Ureshino H
Kubota Y
Ando T
Naito S
Ohshima K
Kimura S
Source :: Annals of hematology [Ann Hematol] 2020 Oct; Vol. 99 (10), pp. 2449-2451. Date of Electronic Publication: 2020 Aug 26.
Publication Year :: 2020

Subjects :: Aged
Antineoplastic Combined Chemotherapy Protocols administration & dosage
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Arthritis, Rheumatoid complications
Arthritis, Rheumatoid drug therapy
Chromosomes, Human, Pair 11 genetics
Chromosomes, Human, Pair 14 genetics
Cyclophosphamide administration & dosage
Doxorubicin administration & dosage
Female
Humans
Immunosuppressive Agents therapeutic use
Lymph Nodes pathology
Lymphoma, Large B-Cell, Diffuse drug therapy
Lymphoma, Large B-Cell, Diffuse genetics
Methotrexate therapeutic use
Neoplasm Proteins genetics
Oncogene Proteins, Fusion genetics
Prednisolone administration & dosage
Remission Induction
Rituximab administration & dosage
Vincristine administration & dosage
Chromosomes, Human, Pair 11 ultrastructure
Chromosomes, Human, Pair 14 ultrastructure
Immunosuppressive Agents adverse effects
Lymphoma, Large B-Cell, Diffuse chemically induced
Methotrexate adverse effects
Neoplasm Proteins analysis
Neprilysin analysis
Oncogene Proteins, Fusion analysis
Proto-Oncogene Proteins c-bcl-6 analysis
Translocation, Genetic

Full Text Access

Tools